Illness perception in overweight and obese patients with cardiovascular diseases

Alessandra Pokrajac-Bulian1, Neala Ambrosi-Randić2

  • 1Department of Psychology, Faculty of Humanities and Social Sciences, University of Rijeka, Rijeka, Croatia. pokrajac@ffri.hr.

Insights

Illness perception and cardiac anxiety are linked to anxiety and depression in cardiovascular disease (CVD) patients. For males, how patients perceive CVD impacts mental health, but this effect differs in females.

Area of Science:

  • Cardiology
  • Psychology
  • Public Health

Background:

  • Cardiovascular diseases (CVD) are a significant health concern, often co-occurring with mental health issues like anxiety and depression.
  • Overweight and obesity are known risk factors for CVD and can exacerbate psychological distress.

Purpose of the Study:

  • To investigate the association between illness perception and cardiac anxiety, general anxiety, and depression in overweight/obese patients with CVD.
  • To explore potential gender differences in these relationships.

Main Methods:

  • A descriptive study involving 165 adult patients (32-89 years) admitted for cardiovascular events or procedures.
  • Psychological assessments included validated questionnaires for illness perception, cardiac anxiety, general anxiety, and depression.

Main Results:

  • Illness perception and cardiac anxiety were significantly associated with general anxiety and depression in the CVD patient sample.
  • Regression analyses indicated that illness perception explained a significant portion of the variance in anxiety and depression for males, but not for females.

Conclusions:

  • The findings highlight a gender-specific relationship between how patients perceive their cardiovascular disease and their mental health outcomes.
  • These gender-specific interrelations suggest the need for tailored interventions to optimize therapeutic effectiveness in CVD patients.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
580
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
293
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
194
Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.8K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K